INDICATORS OF ANTIBODIES IgM AND IgG TO SARS-COV-2 IN RESIDENTS OF YAKUTSK AFTER RECOVERY FROM COVID-19

被引：0
|
作者：
Efremova, S. D. [1 ]
Okhlopkova, E. D. [1 ]
Grigorieva, A. A. [2 ]
Olesova, L. D. [2 ]
Romanova, A. N. [3 ]
机构：
[1] Yakutsk Sci Ctr Complex Med Problems, Lab Immunol, Yakutsk, Russia
[2] Yakutsk Sci Ctr Complex Med Problems, Lab Biochem, Yakutsk, Russia
[3] Yakutsk Sci Ctr Complex Med Problems, Yakutsk, Russia
来源：
YAKUT MEDICAL JOURNAL | 2021年 / 04期
关键词：
IgG; IgM; SARS-CoV-2; antibodies; COVID-19; SEROLOGICAL TESTS;
D O I：
10.25789/YMJ.2021.76.21
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
A study of IgM and IgG antibodies to SARS-COV-2 was carried out in 161 residents of Yakutsk at the age from 20 to 72 years old who had a new coronavirus infection COVID-19 from 3, 6, 9 and 12 months ago. The aim of the work was to assess the content of serum immunoglobulins IgM and IgG to SARS-COV-2 in persons who have had COVID-19, depending on the duration and severity of the disease. The intensity of the immune response was assessed using the coefficient of positivity (CP) as the ratio of the optical density of the sample to the critical value of the optical density. According to the results of the study, the seroprevalence in all 4 groups of patients with Covid-19 was 100%. Antibodies IgG and IgM to SARS-CoV-2 in those who had been ill with COVID-19 persisted up to 12 months and depended on the postcovid period, age and severity of lung lesions on CT.
引用
收藏
页码：85 / 88
页数：4
相关论文
共 50 条
  • [21] Reactivation of SARS-CoV-2 infection following recovery from COVID-19
    Chen, Zhihai
    Xie, Wen
    Ge, Ziruo
    Wang, Yajie
    Zhao, Hong
    Wang, Jingjing
    Xu, Yanli
    Zhang, Wei
    Song, Meihua
    Cui, Shuping
    Wang, Xiankun
    Pan, Calvin Q.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (05) : 620 - 627
  • [22] Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters
    King, Hannah A. D.
    Dussupt, Vincent
    Mendez-Rivera, Letzibeth
    Slike, Bonnie M. M.
    Tran, Ursula
    Jackson, Nathan D. D.
    Barkei, Erica
    Zemil, Michelle
    Tourtellott-Fogt, Emily
    Kuklis, Caitlin H. H.
    Soman, Sandrine
    Ahmed, Aslaa
    Porto, Maciel
    Kitajewski, Christopher
    Spence, Brittany
    Benetiene, Dalia
    Wieczorek, Lindsay
    Kar, Swagata
    Gromowski, Gregory
    Polonis, Victoria R. R.
    Krebs, Shelly J. J.
    Modjarrad, Kayvon
    Bolton, Diane L. L.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] Are IgG and IgM antibodies against the S and N antigens of SARS-CoV-2 always predictors of previous SARS-CoV-2 infection?
    Lippi, Giuseppe
    Henry, Brandon M.
    Pighi, Laura
    De Nitto, Simone
    Salvagno, Gian Luca
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (02): : 180 - 184
  • [24] Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors
    Gaviria, Anibal
    Tamayo-Trujillo, Rafael
    Paz-Cruz, Elius
    Cadena-Ullauri, Santiago
    Guevara-Ramirez, Patricia
    Ruiz-Pozo, Viviana A.
    Cevallos, Francisco
    Aguirre-Tello, Victor
    Risueno, Karla
    Yanez, Martha Paulina
    Cabrera-Andrade, Alejandro
    Zambrano, Ana Karina
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [25] The Seroprevalence of SARS-CoV-2 IgG Antibodies in Children Hospitalized for Reasons Other Than COVID-19
    Franczak, Justyna
    Moppert, Justyna
    Sobolewska-Pilarczyk, Malgorzata
    Pawlowska, Malgorzata
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [26] Analysis of IgG Antibodies against SARS-CoV-2 and Seasonal Coronaviruses in Vaccinated Adults against COVID-19, 2021
    Recalde-Reyes, Delia Piedad
    Rodriguez-Salazar, Carlos Andres
    INFECTIO, 2024, 28 (03) : 145 - 151
  • [27] Validation and performance comparison of two SARS-CoV-2 IgG/IgM rapid tests
    Awaji, Nisreen Naser Al
    Ahmedah, Hanadi Talal
    Alsaady, Isra Mohammed
    Bawaked, Rowaedh Ahmed
    Alraey, Mohammed A.
    Alasiri, Ahmed Ayed
    Alfaifi, Abdullah Mofareh
    Alshehri, Hamdan Ali
    Alserihi, Raed
    Yasin, Elrashed B.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (06) : 3433 - 3437
  • [28] Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease (vol 12, 695230, 2021)
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [29] Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19
    Gacci, M.
    Coppi, M.
    Baldi, E.
    Sebastianelli, A.
    Zaccaro, C.
    Morselli, S.
    Pecoraro, A.
    Manera, A.
    Nicoletti, R.
    Liaci, A.
    Bisegna, C.
    Gemma, L.
    Giancane, S.
    Pollini, S.
    Antonelli, A.
    Lagi, F.
    Marchiani, S.
    Dabizzi, S.
    Degl'Innocenti, S.
    Maggi, M.
    Vignozzi, L.
    Bartoloni, A.
    Rossolini, G. M.
    Serni, S.
    HUMAN REPRODUCTION, 2021, 36 (06) : 1520 - 1529
  • [30] Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19
    Pace, Ryan M.
    Williams, Janet E.
    Jarvinen, Kirsi M.
    Belfort, Mandy B.
    Pace, Christina D. W.
    Lackey, Kimberly A.
    Gogel, Alexandra C.
    Nguyen-Contant, Phuong
    Kanagaiah, Preshetha
    Fitzgerald, Theresa
    Ferri, Rita
    Young, Bridget
    Rosen-Carole, Casey
    Diaz, Nichole
    Meehan, Courtney L.
    Caffe, Beatrice
    Sangster, Mark Y.
    Topham, David
    McGuire, Mark A.
    Seppo, Antti
    McGuire, Michelle K.
    MBIO, 2021, 12 (01): : 1 - 11
12345